Bay Street News, January, 2019

NEWTOWN, Pa., Jan. 22, 2019 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused […]

STAMFORD, Conn., Jan. 22, 2019 (GLOBE NEWSWIRE) — Eagle Bulk Shipping Inc. (NASDAQ: EGLE) (“Eagle” or the “Company”) announced today […]

Publication Highlights Encouraging Evidence of OTL-300’s Safety and Efficacy in Transfusion-Dependent Beta-Thalassemia Patients BOSTON and LONDON, Jan. 22, 2019 (GLOBE […]

RICHMOND, Va., Jan. 22, 2019 (GLOBE NEWSWIRE) — Union Bankshares Corporation (the “Company” or “Union”) (Nasdaq: UBSH) today reported net […]

Six Minute Walk Test Acceptable as Primary Efficacy Endpoint for Potential Registration Program SOUTH SAN FRANCISCO, Calif., Jan. 22, 2019 […]

Breakthrough Therapy Designation granted based on interim data from the Marginal Zone Lymphoma cohort of the UNITY-NHL trial NEW YORK, […]

ATHENS, Greece, Jan. 22, 2019 (GLOBE NEWSWIRE) — TOP Ships Inc. (the “Company”), an international owner and operator of modern, […]

WINTER SPRINGS, Fla., Jan. 22, 2019 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its […]

HOUSTON, Jan. 22, 2019 (GLOBE NEWSWIRE) — Apache Corporation (NYSE, Nasdaq: APA) has been named by FORTUNE magazine as one […]

CAMBRIDGE, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on […]